Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methodsTakeshi Yoroidaka(Kanazawa University), Kosei Matsue(Kameda Medical Center)Scientific ReportsMay 27, 202110.1038/s41598-021-89761-9Cited by 13SaveCiteExport RISWatch citationsRelated PapersHigh frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphoma|Cancer|2011|47Gross Hematopyuria Presenting As a First Symptom Due to the Bladder Infiltration of Extranodal Burkitt's Lymphoma|Journal of Clinical Oncology|2010|9